Variants of Dopamine and Serotonin Candidate Genes as Predictors of Response to Risperidone Treatment in First-Episode Schizophrenia
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
AIMS: Abnormalities in dopaminergic and serotonergic transmission systems are thought to be involved in the pathophysiology of schizophrenia and the mechanisms underlying the therapeutic effects of antipsychotics. We conducted a pharmacogenetic study to evaluate whether variants in dopamine-related genes (DRD1-DRD5, AKT1 and GSK3beta) and serotonin receptor genes (HTR1A, HTR1B, HTR1D, HTR2A, HTR2C, HTR6 and HTR7) can be used to predict the efficacy of risperidone treatment for schizophrenia. MATERIALS & METHODS: A total of 120 first-episode neuroleptic-naive schizophrenia patients were treated with risperidone monotherapy for 8 weeks and clinical symptoms were evaluated by the Positive and Negative Syndrome Scale. RESULTS: Among the 30 variants that we examined, two SNPs in DRD2 (-241A>G [rs1799978] and TaqIA [rs1800497]) and two SNPs in AKT1 (AKT1-SNP1 [rs3803300] and AKT1-SNP5 [rs2494732]) were significant predictors of treatment response to risperidone. CONCLUSION: These data suggest that the SNPs in DRD2 and AKT1 may influence the treatment response to risperidone in schizophrenia patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988 · cited 1×
“This may be because variation in each individual gene may have weak effects [14].”
BackgroundMcCracken, J. T., Smalley, S. L., McGough, J. J., Crawford, L., Del'Homme, M., Cantor, R. M., Liu, A., & Nelson, S. F. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000770 · Cited by 189 · cited 1×
“These include: four SNPs for DRD1 [33]; three variants for DRD2 [12,34]; two SNPs for DRD3 [35]; four variants for DRD4 [36,37]; one SNP for DRD5 [38]; five SNPs for AKT1 [22]; two SNPs for GSK3B [39]; one SNP for HTR1A [40]; one SNP for HTR1B [41]; one SNP for HTR1D [42]; one SNP for HTR2A [12]; two SNPs for HTR2C [4…”
BackgroundThe Dopamine D2 Receptor: New Surprises from an Old Friend
Bonci, A., & Hopf, F. W. (2005) · Neuron · doi:10.1016/j.neuron.2005.07.015 · Cited by 115 · cited 1×
“In addition, variation in signaling cascades downstream of D2 receptor blockage may be associated with treatment of schizophrenia [17].”
Background
Cited by
Personalized medicine in psychiatry: problems and promises
Ozomaro, U., Wahlestedt, C., & Nemeroff, C. B. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-132 · Cited by 270
Hamidovic, A., Dlugos, A., Skol, A., Palmer, A. A., & de Wit, H. (2009) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0017840 · Cited by 108
“…(Laucht et al., 2008); rs1079596, which has been associated with performance on the continuous performance test (Kollins et al., 2008); and rs1125394 and rs1799978, which have been associated with therapeutic responses to clozapine (Hwang et al., 2006) and risperidone (Ikeda et al., 2008).”
BackgroundPolygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia
Wimberley, T., Gasse, C., Meier, S. M., Agerbo, E., MacCabe, J. H., & Horsdal, H. T. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx007 · Cited by 89
Metadata
- Authors
- Ikeda, M., Yamanouchi, Y., Kinoshita, Y., Kitajima, T., Yoshimura, R., Hashimoto, S., O‘Donovan, M. C., Nakamura, J., Ozaki, N., & Iwata, N.
- Venue
- Pharmacogenomics
- Publisher
- Informa UK Limited
- Published
- 2008-10
- Volume
- 9
- Issue
- 10
- Pages
- 1437-1443
- ISSN
- 1462-2416 (ISSN-L)
- 1744-8042
- OpenAlex
- W2097965819
- Cited by
- 110
- References
- 4
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Variants of Dopamine and Serotonin Candidate Genes as Predictors of Response to Risperidone Treatment in First-Episode Schizophrenia. https://app.cochat.ai/papers/10.2217/14622416.9.10.1437
- The paper
- Ikeda, M., Yamanouchi, Y., Kinoshita, Y., Kitajima, T., Yoshimura, R., Hashimoto, S., O‘Donovan, M. C., Nakamura, J., Ozaki, N., & Iwata, N. (2008). Variants of Dopamine and Serotonin Candidate Genes as Predictors of Response to Risperidone Treatment in First-Episode Schizophrenia. Pharmacogenomics. https://doi.org/10.2217/14622416.9.10.1437
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.